Addex Therapeutics Ltd (FRA:APE)

Germany flag Germany · Delayed Price · Currency is EUR
0.0500
0.00 (0.00%)
At close: Oct 10, 2025
Market Cap7.84M
Revenue (ttm)179.11K
Net Income (ttm)-6.48M
Shares Outn/a
EPS (ttm)-0.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0500
Previous Close0.0500
Day's Range0.0500 - 0.0500
52-Week Range0.0030 - 0.0810
Betan/a
RSI51.73
Earnings DateNov 10, 2025

About Addex Therapeutics

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson’s disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mG... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol APE
Full Company Profile

Financial Performance

Financial numbers in CHF Financial Statements

News

There is no news available yet.